SCHEMBL23957686

SCHEMBL23957686

C[C@@H](c1ccc(-n2cccn2)nc1)N(C)c1ccc(Br)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.39
KDM4E B2RXH2 5/20 0.35
OGA O60502 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
CHRNA7 P36544 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
GBA1 P04062 1/20 0.33
MEN1 O00255 1/20 0.33
PCSK9 Q8NBP7 1/20 0.32
TNIK Q9UKE5 1/20 0.32
HPGD P15428 1/20 0.32
RET P07949 1/20 0.32
PANK3 Q9H999 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23929906 0.82 HPGD (0.38) OGAEGLN1ALDH1A1GBA1HPGD
SCHEMBL23929908 0.82 HPGD (0.38) OGAEGLN1ALDH1A1GBA1HPGD
SCHEMBL23929900 0.81 GBA1 (0.35) OGAEGLN1GBA1RETPANK3
SCHEMBL23929953 0.81 EGLN1 (0.36) OGAEGLN1GBA1PANK3
SCHEMBL23929898 0.81 GBA1 (0.35) OGAEGLN1GBA1RETPANK3
SCHEMBL23929954 0.81 EGLN1 (0.36) OGAEGLN1GBA1PANK3
SCHEMBL29275445 0.79 KMT2A (0.38) KMT2ALMNAKDM4EEGLN1ALDH1A1
SCHEMBL23957683 0.79 KMT2A (0.38) KMT2ALMNAKDM4EEGLN1ALDH1A1
SCHEMBL2067481 0.78 LMNA (0.57) KMT2ALMNAKDM4EALDH1A1RXFP1
SCHEMBL23929959 0.78 OGA (0.47) LMNAOGAALDH1A1GBA1PANK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 US disclosed
EP-4141003-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF Shenzhen Zhongge Biological Technology Co., Ltd. (CN) 2023-03-01 EP disclosed
WO-2021213476-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF 深圳晶泰科技有限公司 (CN) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NCOA4, CCDC47, CCDC6 KMT2A 1723/4885LMNA 3326/4885KDM4E 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.